首页 > 最新文献

Journal of the American Academy of Orthopaedic Surgeons最新文献

英文 中文
Microbiological Differences Among Age Groups in Patients Diagnosed With Periprosthetic Joint Infection: A Database Analysis of 2,392 Patients. 不同年龄段假体周围关节感染患者的微生物学差异:2392 例患者的数据库分析。
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-30 DOI: 10.5435/JAAOS-D-24-00214
Seper Ekhtiari, Franka Mai, Taner Karlidag, Thorsten Gehrke, Mustafa Citak

Introduction: Periprosthetic joint infection (PJI) after total joint arthroplasty (TJA) poses substantial economic and quality-of-life challenges. With the rising incidence of hip and knee arthritis globally, understanding the changing profile of PJIs across different age groups becomes crucial. While various studies have explored risk factors, the influence of age on PJI remains debated, with potential bimodal relationships. This study aims to investigate the causative organisms of PJIs in patients of different age groups undergoing TJA.

Methods: Conducted as a retrospective cohort study at a high-volume PJI referral center, the study adhered to Strengthening the Reporting of Observational Studies in Epidemiology guidelines. Data spanned from January 1, 2001, to December 31, 2022, including patients with documented PJI undergoing revision TJA. Patients were categorized into age quintiles, and outcomes analyzed included causative organisms, difficult-to-treat infections, antimicrobial resistance, and Gram stain characteristics. Statistical analyses used descriptive statistics, chi-square tests, and sensitivity analyses for hip and knee patients separately.

Results: The study comprised 2,392 patients, with 60.7% undergoing hip arthroplasty and 39.3% undergoing knee arthroplasty. 1,080 women (45.2%) and 1,312 men (54.8%) were included. Older patients were markedly more likely to have gram-negative infections and atypical infections. Patients in the youngest age group had the lowest rates of methicillin-resistant Staphylococcus aureus infection. Results were similar between hip and knee PJIs.

Conclusions: The study reveals age-related variations in the characteristics of PJIs after TJA, emphasizing higher risks of atypical and resistant infections in older patients. These findings underscore the importance of tailored preventive measures and potential considerations for adjunctive or prolonged antibiotic therapies, especially in the elderly population. Recognizing the unique infection patterns in older patients may inform better prevention and treatment strategies, with implications for enhanced patient care and outcomes. Future directions should focus on patient-specific strategies for preventing and treating PJIs, particularly in high-risk populations.

导言:全关节置换术(TJA)后的假体周围关节感染(PJI)给经济和生活质量带来了巨大挑战。随着全球髋关节和膝关节炎发病率的上升,了解不同年龄组 PJI 的变化情况变得至关重要。虽然已有多项研究探讨了风险因素,但年龄对 PJI 的影响仍存在争议,可能存在双峰关系。本研究旨在调查接受 TJA 手术的不同年龄组患者中 PJI 的致病菌:该研究是在一个高容量 PJI 转诊中心进行的一项回顾性队列研究,遵循了《加强流行病学中观察性研究的报告》指南。数据时间跨度为2001年1月1日至2022年12月31日,包括接受翻修TJA的有记录的PJI患者。患者年龄分为五等分,分析结果包括致病菌、难治性感染、抗菌素耐药性和革兰氏染色特征。统计分析采用了描述性统计、卡方检验,并分别对髋关节和膝关节患者进行了敏感性分析:这项研究包括 2392 名患者,其中 60.7% 接受髋关节置换术,39.3% 接受膝关节置换术。其中有 1080 名女性(45.2%)和 1312 名男性(54.8%)。老年患者明显更容易发生革兰氏阴性菌感染和非典型感染。最年轻年龄组患者的耐甲氧西林金黄色葡萄球菌感染率最低。髋关节和膝关节PJI的结果相似:该研究揭示了 TJA 术后 PJIs 特征中与年龄相关的变化,强调了老年患者发生非典型感染和耐药感染的风险较高。这些发现强调了针对性预防措施的重要性,以及辅助或长期抗生素疗法的潜在考虑因素,尤其是在老年人群中。认识到老年患者的独特感染模式可以为更好的预防和治疗策略提供依据,从而改善患者护理和治疗效果。未来的发展方向应侧重于针对特定患者的 PJI 预防和治疗策略,尤其是在高危人群中。
{"title":"Microbiological Differences Among Age Groups in Patients Diagnosed With Periprosthetic Joint Infection: A Database Analysis of 2,392 Patients.","authors":"Seper Ekhtiari, Franka Mai, Taner Karlidag, Thorsten Gehrke, Mustafa Citak","doi":"10.5435/JAAOS-D-24-00214","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00214","url":null,"abstract":"<p><strong>Introduction: </strong>Periprosthetic joint infection (PJI) after total joint arthroplasty (TJA) poses substantial economic and quality-of-life challenges. With the rising incidence of hip and knee arthritis globally, understanding the changing profile of PJIs across different age groups becomes crucial. While various studies have explored risk factors, the influence of age on PJI remains debated, with potential bimodal relationships. This study aims to investigate the causative organisms of PJIs in patients of different age groups undergoing TJA.</p><p><strong>Methods: </strong>Conducted as a retrospective cohort study at a high-volume PJI referral center, the study adhered to Strengthening the Reporting of Observational Studies in Epidemiology guidelines. Data spanned from January 1, 2001, to December 31, 2022, including patients with documented PJI undergoing revision TJA. Patients were categorized into age quintiles, and outcomes analyzed included causative organisms, difficult-to-treat infections, antimicrobial resistance, and Gram stain characteristics. Statistical analyses used descriptive statistics, chi-square tests, and sensitivity analyses for hip and knee patients separately.</p><p><strong>Results: </strong>The study comprised 2,392 patients, with 60.7% undergoing hip arthroplasty and 39.3% undergoing knee arthroplasty. 1,080 women (45.2%) and 1,312 men (54.8%) were included. Older patients were markedly more likely to have gram-negative infections and atypical infections. Patients in the youngest age group had the lowest rates of methicillin-resistant Staphylococcus aureus infection. Results were similar between hip and knee PJIs.</p><p><strong>Conclusions: </strong>The study reveals age-related variations in the characteristics of PJIs after TJA, emphasizing higher risks of atypical and resistant infections in older patients. These findings underscore the importance of tailored preventive measures and potential considerations for adjunctive or prolonged antibiotic therapies, especially in the elderly population. Recognizing the unique infection patterns in older patients may inform better prevention and treatment strategies, with implications for enhanced patient care and outcomes. Future directions should focus on patient-specific strategies for preventing and treating PJIs, particularly in high-risk populations.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intranasal Fentanyl Versus Morphine in Fracture Reduction in a Pediatric Trauma Center. 在儿科创伤中心,鼻内芬太尼与吗啡在骨折复位中的应用
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-30 DOI: 10.5435/JAAOS-D-24-00231
Raoul Bisso, Alexandra Tielli, Anne-Aurelie Lopes

Purpose: Pain management in orthopaedic manipulation in the emergency department (ED) is crucial to decrease fracture reduction performed in the operating room. This study compared intranasal fentanyl (INF) with oral morphine in time of care and effectiveness on pain during the reduction of bone fractures in a pediatric trauma center.

Methods: A before-and-after INF implementation study was conducted in a pediatric ED with a trauma center on children with a confirmed displaced closed fracture on radiographs with reduction and casting performed in the ED. The time of care, time for sufficient analgesia, effectiveness on pain, and tolerance were compared between both analgesics in 3 consecutive phases.

Results: 77 children were included: 31 children received oral morphine and 46 INF. The time of care was shorter in the INF group (150 [111 to 193] minutes versus 215 [155 to 240], P = 0.01) as the time for sufficient analgesia (10 [9 to 13] minutes versus 80 [53 to 119], P < 0.001) with a higher pain reduction after a dose of INF (3 [0 to 4] versus 6 [3 to 7], P < 0.001) and less dose requirement (P = 0.002). Although pain scores were similar at arrival in both groups (P = 0.15), the pain was significantly lower before and during the procedure in the INF group and equivalent after the procedure (2 [0 to 4] versus 3 [0 to 5], P = 0.02, 3 [1 to 5] versus 7 [3 to 9], P < 0.001, and 1 [0 to 2] in both groups, P = 0.87, respectively). Keeping pain levels low during the procedure in the INF group allowed the extension to lower limb fracture reductions (P = 0.04). No serious adverse events were reported.

Conclusion: INF reduces the time to obtain sufficient analgesia and time of care, with good effectiveness maintained during the procedure in fracture reduction, allowing the extension to lower limb fractures. Thus, this rapid and efficient analgesia facilitates orthopaedic care in the pediatric ED that would otherwise require to be reduced in the operating room under general anesthesia.

目的:急诊科(ED)骨科手术中的疼痛管理对于减少手术室中的骨折复位至关重要。本研究比较了鼻内注射芬太尼(INF)和口服吗啡在儿科创伤中心骨折复位术中的护理时间和止痛效果:方法:在创伤中心的儿科急诊室进行了一项INF实施前后对比研究,研究对象是在急诊室进行骨折复位和石膏固定的儿童。在连续 3 个阶段对两种镇痛药的治疗时间、充分镇痛时间、镇痛效果和耐受性进行了比较:结果:共纳入 77 名儿童:结果:共纳入 77 名儿童:31 名儿童口服吗啡,46 名儿童口服 INF。INF 组的护理时间较短(150 [111 至 193] 分钟对 215 [155 至 240],P = 0.01),充分镇痛时间也较短(10 [9 至 13] 分钟对 80 [53 至 119],P < 0.001),服用 INF 后疼痛减轻程度较高(3 [0 至 4] 对 6 [3 至 7],P < 0.001),所需剂量较少(P = 0.002)。虽然两组患者到达时的疼痛评分相似(P = 0.15),但 INF 组患者在手术前和手术过程中的疼痛明显更低(2 [0 至 4] 对 3 [0 至 5],P = 0.02;3 [1 至 5] 对 7 [3 至 9],P < 0.001;两组均为 1 [0 至 2],P = 0.87)。INF组在手术过程中保持较低的疼痛水平,使下肢骨折复位得以延长(P = 0.04)。无严重不良事件报告:INF缩短了获得充分镇痛的时间和护理时间,并在骨折复位过程中保持良好的效果,使手术范围扩大到下肢骨折。因此,这种快速有效的镇痛方法有助于儿科急诊室的骨科治疗,否则,这些治疗将需要在手术室全身麻醉下进行。
{"title":"Intranasal Fentanyl Versus Morphine in Fracture Reduction in a Pediatric Trauma Center.","authors":"Raoul Bisso, Alexandra Tielli, Anne-Aurelie Lopes","doi":"10.5435/JAAOS-D-24-00231","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00231","url":null,"abstract":"<p><strong>Purpose: </strong>Pain management in orthopaedic manipulation in the emergency department (ED) is crucial to decrease fracture reduction performed in the operating room. This study compared intranasal fentanyl (INF) with oral morphine in time of care and effectiveness on pain during the reduction of bone fractures in a pediatric trauma center.</p><p><strong>Methods: </strong>A before-and-after INF implementation study was conducted in a pediatric ED with a trauma center on children with a confirmed displaced closed fracture on radiographs with reduction and casting performed in the ED. The time of care, time for sufficient analgesia, effectiveness on pain, and tolerance were compared between both analgesics in 3 consecutive phases.</p><p><strong>Results: </strong>77 children were included: 31 children received oral morphine and 46 INF. The time of care was shorter in the INF group (150 [111 to 193] minutes versus 215 [155 to 240], P = 0.01) as the time for sufficient analgesia (10 [9 to 13] minutes versus 80 [53 to 119], P < 0.001) with a higher pain reduction after a dose of INF (3 [0 to 4] versus 6 [3 to 7], P < 0.001) and less dose requirement (P = 0.002). Although pain scores were similar at arrival in both groups (P = 0.15), the pain was significantly lower before and during the procedure in the INF group and equivalent after the procedure (2 [0 to 4] versus 3 [0 to 5], P = 0.02, 3 [1 to 5] versus 7 [3 to 9], P < 0.001, and 1 [0 to 2] in both groups, P = 0.87, respectively). Keeping pain levels low during the procedure in the INF group allowed the extension to lower limb fracture reductions (P = 0.04). No serious adverse events were reported.</p><p><strong>Conclusion: </strong>INF reduces the time to obtain sufficient analgesia and time of care, with good effectiveness maintained during the procedure in fracture reduction, allowing the extension to lower limb fractures. Thus, this rapid and efficient analgesia facilitates orthopaedic care in the pediatric ED that would otherwise require to be reduced in the operating room under general anesthesia.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changing Epidemiology of Distal Femur Fractures: Increase in Geriatric Fractures and Rates of Distal Femur Replacement. 股骨远端骨折流行病学的变化:股骨远端骨折流行病学的变化:老年骨折的增加和股骨远端置换率的上升。
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-30 DOI: 10.5435/JAAOS-D-24-00007
Graham DeKeyser, Tyler Thorne, Brook I Martin, Justin M Haller

Introduction: Distal femur fractures (DFFs) are associated with high complication and mortality rates in the elderly. Using the National Inpatient Sample and Medicare data, we describe trends in the incidence of DFFs by fixation type and associated healthcare costs.

Methods: Annual population rates and volume of inpatient DFFs were estimated using Poisson regression with the US Census as a denominator. We used Current Procedural Terminology codes in Medicare patients to determine episode-of-care cost by treatment, classified as intramedullary nail, open reduction and internal fixation, and distal femur arthroplasty (DFR).

Results: The annual incidence of DFFs in the United States is approximately 27.4 per 100,000. Admission for DFFs increased from 2002 to 2020, with the highest volume and rate in those aged 85 years and older. DFF incidence increased (1.95×) from 142 per 1 million (95% CI: 140 to 144) in 2006 to 281 per 1 million (95% CI: 278-284) in 2019. From 2012 to 2019, the percentage of DFFs treated by intramedullary nail increased from 6.8% to 8.4%, open reduction and internal fixation decreased from 89.9% to 76.6%, and DFR increased from 3.3% to 14.9%. DFR cost was significantly greater than other treatment choices across all years for initial inpatient admission costs and 90-day episode-of-care costs (all P < 0.0001).

Conclusion: DFF volume has increased in the past 20 years, predominantly in elderly patients. Greater than 4.5× increase was observed in the proportion of geriatric DFFs treated with DFR during this study period. The total cost of DFR treatment was consistently greater than other surgical treatments.

简介股骨远端骨折(DFF)与老年人的高并发症和高死亡率有关。利用全国住院病人抽样调查和医疗保险数据,我们按固定类型和相关医疗费用描述了股骨远端骨折发病率的趋势:方法:以美国人口普查为分母,使用泊松回归法估算了DFF的年人口比率和住院量。我们使用医疗保险(Medicare)患者的 "当前手术术语"(Current Procedural Terminology)代码来确定按髓内钉、切开复位内固定术和股骨远端关节成形术(DFR)分类的治疗费用:美国股骨远端骨折的年发病率约为十万分之27.4。从 2002 年到 2020 年,DFF 的入院人数有所增加,其中 85 岁及以上人群的入院人数和入院率最高。DFF发病率从2006年的142/100万(95% CI:140至144)增加到2019年的281/100万(95% CI:278至284)(1.95倍)。从2012年到2019年,采用髓内钉治疗的DFF比例从6.8%上升到8.4%,开放复位和内固定从89.9%下降到76.6%,DFR从3.3%上升到14.9%。在所有年份中,DFR的初始住院费用和90天的护理费用均明显高于其他治疗选择(所有P < 0.0001):结论:在过去 20 年中,DFF 的治疗量有所增加,主要是老年患者。在本研究期间,接受 DFR 治疗的老年 DFF 患者比例增加了 4.5 倍以上。DFR治疗的总费用一直高于其他手术治疗。
{"title":"Changing Epidemiology of Distal Femur Fractures: Increase in Geriatric Fractures and Rates of Distal Femur Replacement.","authors":"Graham DeKeyser, Tyler Thorne, Brook I Martin, Justin M Haller","doi":"10.5435/JAAOS-D-24-00007","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00007","url":null,"abstract":"<p><strong>Introduction: </strong>Distal femur fractures (DFFs) are associated with high complication and mortality rates in the elderly. Using the National Inpatient Sample and Medicare data, we describe trends in the incidence of DFFs by fixation type and associated healthcare costs.</p><p><strong>Methods: </strong>Annual population rates and volume of inpatient DFFs were estimated using Poisson regression with the US Census as a denominator. We used Current Procedural Terminology codes in Medicare patients to determine episode-of-care cost by treatment, classified as intramedullary nail, open reduction and internal fixation, and distal femur arthroplasty (DFR).</p><p><strong>Results: </strong>The annual incidence of DFFs in the United States is approximately 27.4 per 100,000. Admission for DFFs increased from 2002 to 2020, with the highest volume and rate in those aged 85 years and older. DFF incidence increased (1.95×) from 142 per 1 million (95% CI: 140 to 144) in 2006 to 281 per 1 million (95% CI: 278-284) in 2019. From 2012 to 2019, the percentage of DFFs treated by intramedullary nail increased from 6.8% to 8.4%, open reduction and internal fixation decreased from 89.9% to 76.6%, and DFR increased from 3.3% to 14.9%. DFR cost was significantly greater than other treatment choices across all years for initial inpatient admission costs and 90-day episode-of-care costs (all P < 0.0001).</p><p><strong>Conclusion: </strong>DFF volume has increased in the past 20 years, predominantly in elderly patients. Greater than 4.5× increase was observed in the proportion of geriatric DFFs treated with DFR during this study period. The total cost of DFR treatment was consistently greater than other surgical treatments.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Anesthetic Regimen on Bone Cement Implantation Syndrome in Cemented Hemiarthroplasty for Hip Fracture. 麻醉方案对髋部骨折骨水泥半关节成形术中骨水泥植入综合征的影响
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-30 DOI: 10.5435/JAAOS-D-24-00239
Ryley K Zastrow, Sandesh S Rao, Carol D Morris, Adam S Levin

Introduction: Bone cement implantation syndrome (BCIS) is characterized by hypoxia, hypotension, and cardiovascular compromise during cementation in arthroplasty cases. This study examines the association between anesthetic regimen and risk of BCIS in cemented hemiarthroplasty for hip fractures. We hypothesized that neuraxial anesthesia would be associated with markedly lower BCIS incidence compared with general anesthesia alone or in combination with regional anesthesia.

Methods: This retrospective cohort study included patients aged 50 years or older who underwent cemented hemiarthroplasty for hip fractures at a single institution between January 2017 and December 2022. Patient demographics, comorbidities, procedural factors, anesthetic characteristics including anesthetic regimen (general, general plus regional, or neuraxial), cement timing, BCIS development, postoperative complications, and mortality data were extracted. BCIS was identified by changes in postcementation vitals and its severity classified according to previously established criteria. Univariate statistical analyses and multivariate logistic regression were conducted.

Results: Of the 137 included patients, 58 (43%) developed BCIS. No notable differences were observed in demographics, comorbidities, or procedural characteristics between patients who developed BCIS and those who did not. However, anesthetic regimen was markedly correlated with BCIS development, with general anesthesia demonstrating the highest rates (26/43, 55%), followed by general plus regional anesthesia (26/58, 45%) and neuraxial anesthesia (6/32, 19%; P = 0.005). Compared with neuraxial anesthesia, general anesthesia and general plus regional anesthesia conferred 6.8 and 5.5 times greater odds of developing BCIS, respectively. The development of BCIS was associated with significantly higher rates of postoperative hypoxia (P = 0.04) and unplanned prolonged intubation (P = 0.04).

Conclusion: BCIS was highly prevalent among patients undergoing cemented hemiarthroplasty for hip fractures. The anesthetic regimen was the only variable markedly associated with BCIS development and is a potentially modifiable risk factor.

Level of evidence: III.

导言:骨水泥植入综合征(BCIS)的特征是关节置换术病例在骨水泥植入过程中出现缺氧、低血压和心血管损害。本研究探讨了髋部骨折骨水泥半关节成形术中麻醉方案与 BCIS 风险之间的关系。我们假设,与单独使用全身麻醉或结合区域麻醉相比,神经轴麻醉将显著降低BCIS的发生率:这项回顾性队列研究纳入了2017年1月至2022年12月期间在一家机构接受骨水泥半关节成形术治疗的50岁或以上髋部骨折患者。研究提取了患者的人口统计学特征、合并症、手术因素、麻醉特征,包括麻醉方案(全麻、全麻加区域麻醉或神经麻醉)、骨水泥时间、BCIS发生情况、术后并发症和死亡率数据。根据手术后生命体征的变化确定 BCIS,并根据之前制定的标准对其严重程度进行分类。进行了单变量统计分析和多变量逻辑回归分析:结果:在纳入的 137 名患者中,58 人(43%)出现了 BCIS。发生 BCIS 的患者与未发生 BCIS 的患者在人口统计学、合并症或手术特征方面没有明显差异。但是,麻醉方案与 BCIS 的发生明显相关,其中全身麻醉的发生率最高(26/43,55%),其次是全身加区域麻醉(26/58,45%)和神经轴麻醉(6/32,19%;P = 0.005)。与神经麻醉相比,全身麻醉和全身加区域麻醉导致发生 BCIS 的几率分别高出 6.8 倍和 5.5 倍。BCIS的发生与较高的术后缺氧率(P = 0.04)和意外延长插管率(P = 0.04)有关:结论:在接受骨水泥半关节成形术治疗髋部骨折的患者中,BCIS的发病率很高。结论:在接受骨水泥半关节成形术治疗的髋部骨折患者中,BCIS的发生率很高。麻醉方案是与BCIS发生明显相关的唯一变量,也是一个潜在的可改变的风险因素:证据等级:III。
{"title":"The Effect of Anesthetic Regimen on Bone Cement Implantation Syndrome in Cemented Hemiarthroplasty for Hip Fracture.","authors":"Ryley K Zastrow, Sandesh S Rao, Carol D Morris, Adam S Levin","doi":"10.5435/JAAOS-D-24-00239","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00239","url":null,"abstract":"<p><strong>Introduction: </strong>Bone cement implantation syndrome (BCIS) is characterized by hypoxia, hypotension, and cardiovascular compromise during cementation in arthroplasty cases. This study examines the association between anesthetic regimen and risk of BCIS in cemented hemiarthroplasty for hip fractures. We hypothesized that neuraxial anesthesia would be associated with markedly lower BCIS incidence compared with general anesthesia alone or in combination with regional anesthesia.</p><p><strong>Methods: </strong>This retrospective cohort study included patients aged 50 years or older who underwent cemented hemiarthroplasty for hip fractures at a single institution between January 2017 and December 2022. Patient demographics, comorbidities, procedural factors, anesthetic characteristics including anesthetic regimen (general, general plus regional, or neuraxial), cement timing, BCIS development, postoperative complications, and mortality data were extracted. BCIS was identified by changes in postcementation vitals and its severity classified according to previously established criteria. Univariate statistical analyses and multivariate logistic regression were conducted.</p><p><strong>Results: </strong>Of the 137 included patients, 58 (43%) developed BCIS. No notable differences were observed in demographics, comorbidities, or procedural characteristics between patients who developed BCIS and those who did not. However, anesthetic regimen was markedly correlated with BCIS development, with general anesthesia demonstrating the highest rates (26/43, 55%), followed by general plus regional anesthesia (26/58, 45%) and neuraxial anesthesia (6/32, 19%; P = 0.005). Compared with neuraxial anesthesia, general anesthesia and general plus regional anesthesia conferred 6.8 and 5.5 times greater odds of developing BCIS, respectively. The development of BCIS was associated with significantly higher rates of postoperative hypoxia (P = 0.04) and unplanned prolonged intubation (P = 0.04).</p><p><strong>Conclusion: </strong>BCIS was highly prevalent among patients undergoing cemented hemiarthroplasty for hip fractures. The anesthetic regimen was the only variable markedly associated with BCIS development and is a potentially modifiable risk factor.</p><p><strong>Level of evidence: </strong>III.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the Gap: Advocating for Medical Students Without Home Orthopaedic Surgery Programs. 缩小差距:为没有家庭骨科手术课程的医科学生进行宣传。
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-30 DOI: 10.5435/JAAOS-D-24-00495
Sean A Tabaie, Sarah Dance, Julie B Samora

Medical students without a home orthopaedic surgery program face unique challenges due to the absence of institutional connections and mentorship opportunities. This review explores the hurdles faced by these students, including financial constraints, emotional strains, mentorship gaps, and networking hurdles. Drawing from empirical evidence and scholarly research, tailored advocacy strategies to empower these medical students pursuing orthopaedic surgery residency are proposed, including mentorship programs, financial assistance, psychosocial support, and community-building initiatives.

由于缺乏院校联系和导师指导机会,没有就读骨科外科专业的医学生面临着独特的挑战。这篇综述探讨了这些学生所面临的障碍,包括经济限制、情感压力、导师差距和网络障碍。根据经验证据和学术研究,提出了量身定制的宣传策略,包括导师计划、经济援助、社会心理支持和社区建设计划,以增强这些追求矫形外科住院医师培训的医学生的能力。
{"title":"Bridging the Gap: Advocating for Medical Students Without Home Orthopaedic Surgery Programs.","authors":"Sean A Tabaie, Sarah Dance, Julie B Samora","doi":"10.5435/JAAOS-D-24-00495","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00495","url":null,"abstract":"<p><p>Medical students without a home orthopaedic surgery program face unique challenges due to the absence of institutional connections and mentorship opportunities. This review explores the hurdles faced by these students, including financial constraints, emotional strains, mentorship gaps, and networking hurdles. Drawing from empirical evidence and scholarly research, tailored advocacy strategies to empower these medical students pursuing orthopaedic surgery residency are proposed, including mentorship programs, financial assistance, psychosocial support, and community-building initiatives.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the Letter to the Editor: Risk Factors Associated with Thromboembolic Complications Following Total Hip Arthroplasty: An Analysis of 1,129 Pulmonary Emboli. 回应致编辑的信:全髋关节置换术后血栓栓塞并发症的相关风险因素:对 1,129 例肺栓塞的分析。
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-29 DOI: 10.5435/JAAOS-D-24-00667
Kevin C Liu, Neelesh Bagrodia, Mary K Richardson, Amit S Piple, Nicholas Kusnezov, Jennifer C Wang, Jay R Lieberman, Nathanael D Heckmann
{"title":"Response to the Letter to the Editor: Risk Factors Associated with Thromboembolic Complications Following Total Hip Arthroplasty: An Analysis of 1,129 Pulmonary Emboli.","authors":"Kevin C Liu, Neelesh Bagrodia, Mary K Richardson, Amit S Piple, Nicholas Kusnezov, Jennifer C Wang, Jay R Lieberman, Nathanael D Heckmann","doi":"10.5435/JAAOS-D-24-00667","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00667","url":null,"abstract":"","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgeon Prescribing Patterns And Perioperative Risk Factors Associated With Prolonged Opioid Use After Total Shoulder Arthroplasty. 外科医生的处方模式以及与全肩关节置换术后长期使用阿片类药物相关的围手术期风险因素。
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-23 DOI: 10.5435/JAAOS-D-24-00051
Joshua D Pezzulo, Dominic M Farronato, Robert Juniewicz, Liam T Kane, Alec S Kellish, Daniel E Davis

Introduction: The opioid epidemic in the United States has contributed to a notable economic burden and increased mortality. Total shoulder arthroplasty (TSA) has become more prevalent, and opioids are commonly used for postoperative pain management. Prolonged opioid use has been associated with adverse outcomes, but the role of surgeons in this context remains unclear. This study aims to investigate the incidence and risk factors of prolonged opioid utilization after primary TSA.

Methods: After obtaining institutional review board approval, a retrospective review of 4,488 primary total shoulder arthroplasties from 2014 to 2022 at a single academic institution was conducted. Patients were stratified by preoperative and postoperative opioid use, and demographic, clinical, and prescription data were collected. Prescriptions filled beyond 30 days after the index operation were considered prolonged use. Multivariate analysis was conducted to determine the independent risk factors associated with prolonged opioid utilization.

Results: Among 4,488 patients undergoing primary TSA, 22% of patients developed prolonged opioid use with 70% of prolonged users being opioid-exposed preoperatively. Independent risk factors of prolonged use include patient age younger than 65 years (Odds Ratio (OR) 1.02, P < 0.001), female sex (OR 1.41, P < 0.001), race other than Caucasian (OR 1.36, P = 0.003), undergoing reverse TSA (OR 1.28, P = 0.010), residing in an urban community (OR 1.33, P = 0.039), preoperative opioid utilization (OR 6.41, P < 0.001), preoperative benzodiazepine utilization (OR 1.93, P < 0.001), and increased postoperative day 1-30 milligram morphine equivalent (OR 1.003, P < 0.001).

Discussion: Nearly 22% of patients experienced prolonged opioid use, with preoperative opioid exposure being the most notable risk factor in addition to postoperative prescribing patterns and benzodiazepine utilization. Surgeons play a crucial role in opioid management, and understanding the risk factors can help optimize benefits while minimizing the associated risks of prolonged opioid use. Additional research is needed to establish standardized definitions and strategies for safe opioid use in orthopaedic surgery.

导言:阿片类药物在美国的流行造成了显著的经济负担和死亡率上升。全肩关节置换术(TSA)越来越普遍,阿片类药物通常用于术后疼痛治疗。长期使用阿片类药物与不良后果有关,但外科医生在其中扮演的角色尚不明确。本研究旨在调查原发性 TSA 术后长期使用阿片类药物的发生率和风险因素:在获得机构审查委员会批准后,我们对一家学术机构在 2014 年至 2022 年期间进行的 4488 例初次全肩关节置换术进行了回顾性研究。根据术前和术后阿片类药物使用情况对患者进行了分层,并收集了人口统计学、临床和处方数据。指标手术后超过 30 天的处方被视为长期使用。研究人员进行了多变量分析,以确定与长期使用阿片类药物相关的独立风险因素:在4488名接受初级TSA手术的患者中,22%的患者长期使用阿片类药物,其中70%的长期使用者在术前接触过阿片类药物。长期使用阿片类药物的独立风险因素包括:患者年龄小于 65 岁(Odds Ratio (OR) 1.02,P < 0.001)、性别为女性(OR 1.41,P < 0.001)、种族非白种人(OR 1.36,P = 0.003)、接受反向 TSA(OR 1.28,P = 0.010)、居住在城市社区(OR 1.33,P = 0.039)、术前使用阿片类药物(OR 6.41,P <0.001)、术前使用苯二氮卓(OR 1.93,P <0.001)、术后第 1-30 毫克吗啡当量增加(OR 1.003,P <0.001):近22%的患者长期使用阿片类药物,除术后处方模式和苯二氮卓使用外,术前阿片类药物暴露是最显著的风险因素。外科医生在阿片类药物管理中起着至关重要的作用,了解风险因素有助于优化收益,同时最大限度地降低长期使用阿片类药物的相关风险。还需要开展更多的研究,为骨科手术中阿片类药物的安全使用制定标准化的定义和策略。
{"title":"Surgeon Prescribing Patterns And Perioperative Risk Factors Associated With Prolonged Opioid Use After Total Shoulder Arthroplasty.","authors":"Joshua D Pezzulo, Dominic M Farronato, Robert Juniewicz, Liam T Kane, Alec S Kellish, Daniel E Davis","doi":"10.5435/JAAOS-D-24-00051","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00051","url":null,"abstract":"<p><strong>Introduction: </strong>The opioid epidemic in the United States has contributed to a notable economic burden and increased mortality. Total shoulder arthroplasty (TSA) has become more prevalent, and opioids are commonly used for postoperative pain management. Prolonged opioid use has been associated with adverse outcomes, but the role of surgeons in this context remains unclear. This study aims to investigate the incidence and risk factors of prolonged opioid utilization after primary TSA.</p><p><strong>Methods: </strong>After obtaining institutional review board approval, a retrospective review of 4,488 primary total shoulder arthroplasties from 2014 to 2022 at a single academic institution was conducted. Patients were stratified by preoperative and postoperative opioid use, and demographic, clinical, and prescription data were collected. Prescriptions filled beyond 30 days after the index operation were considered prolonged use. Multivariate analysis was conducted to determine the independent risk factors associated with prolonged opioid utilization.</p><p><strong>Results: </strong>Among 4,488 patients undergoing primary TSA, 22% of patients developed prolonged opioid use with 70% of prolonged users being opioid-exposed preoperatively. Independent risk factors of prolonged use include patient age younger than 65 years (Odds Ratio (OR) 1.02, P < 0.001), female sex (OR 1.41, P < 0.001), race other than Caucasian (OR 1.36, P = 0.003), undergoing reverse TSA (OR 1.28, P = 0.010), residing in an urban community (OR 1.33, P = 0.039), preoperative opioid utilization (OR 6.41, P < 0.001), preoperative benzodiazepine utilization (OR 1.93, P < 0.001), and increased postoperative day 1-30 milligram morphine equivalent (OR 1.003, P < 0.001).</p><p><strong>Discussion: </strong>Nearly 22% of patients experienced prolonged opioid use, with preoperative opioid exposure being the most notable risk factor in addition to postoperative prescribing patterns and benzodiazepine utilization. Surgeons play a crucial role in opioid management, and understanding the risk factors can help optimize benefits while minimizing the associated risks of prolonged opioid use. Additional research is needed to establish standardized definitions and strategies for safe opioid use in orthopaedic surgery.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142086415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Case Volume Reported by Musculoskeletal Oncology Fellows in Accreditation Council for Graduate Medical Education-Accredited Training Programs: 2017 to 2022. 肌肉骨骼肿瘤学研究员在毕业医学教育认证委员会认可的培训项目中报告的病例量趋势:2017 年至 2022 年。
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-23 DOI: 10.5435/JAAOS-D-24-00012
Jason Silvestre, Zeke J Walton, Lee R Leddy

Introduction: Increasingly, national accrediting bodies and professional societies for musculoskeletal oncology recognize the need for more standardized training. This study elucidates recent trends in reported case volume during Accreditation Council for Graduate Medical Education (ACGME)-accredited musculoskeletal oncology fellowship training relative to case minimum requirements.

Methods: We conducted a retrospective cross-sectional analysis of fellows at ACGME-accredited musculoskeletal oncology fellowships (2017 to 2022). Percentiles in reported case volumes were calculated across ACGME-defined case categories and temporal changes assessed by linear regression. Variability between the highest (90th percentile) and lowest (10th percentile) deciles was calculated as fold differences. Sensitivity analyses were conducted to estimate the number of fellows not meeting ACGME-defined case minimum requirements.

Results: Case logs from 95 musculoskeletal oncology fellows were analyzed. From 2017 to 2022, total relevant oncology procedures increased from 191 ± 49 to 228 ± 73 (P = 0.066). Pediatric oncology accounted for a minority of cases (range, 6 to 8%). A mean of 222 total relevant oncology procedures were reported. Most were in management of metastatic disease (21%), soft-tissue resection/reconstruction (20%), and limb salvage (13%). Variability in total relevant oncology procedures was 2.6 and greatest in spine/pelvis (4.6), pediatric oncologic cases (4.4), and surgical management of complications (4.4). No clear trends were observed in case volume variability over the study period (P > 0.05). Analysis of case volume percentiles identified at least 30% of musculoskeletal oncology fellows not achieving minimum requirements for pediatric oncologic cases (n = 29 fellows) and 10% of fellows not achieving minimum requirements for total relevant oncology procedures (n = 10 fellows).

Discussion: Results from this study may help future musculoskeletal oncology fellows and faculty identify potential areas to increase case exposure and reduce variability during fellowship training. More investigation is needed to determine evidence-based case minimum requirements including surgical learning curves and other competency-based assessment tools in musculoskeletal oncology.

导言:越来越多的国家认证机构和肌肉骨骼肿瘤学专业协会认识到需要开展更加标准化的培训。本研究阐明了在毕业后医学教育认证委员会(ACGME)认证的肌肉骨骼肿瘤学研究员培训期间,报告病例量相对于病例最低要求的最新趋势:我们对获得 ACGME 认证的肌肉骨骼肿瘤学研究员进行了一项回顾性横断面分析(2017 年至 2022 年)。我们计算了ACGME定义的病例类别中报告病例量的百分位数,并通过线性回归评估了时间变化。最高百分位数(第 90 个百分位数)和最低百分位数(第 10 个百分位数)之间的变异以折合差计算。进行了敏感性分析,以估计未达到 ACGME 定义的病例最低要求的研究员人数:对 95 名肌肉骨骼肿瘤学研究员的病例日志进行了分析。从 2017 年到 2022 年,相关肿瘤学手术总数从 191 ± 49 增加到 228 ± 73(P = 0.066)。儿科肿瘤占少数(6%至8%)。报告的相关肿瘤手术总数平均为 222 例。其中大部分用于治疗转移性疾病(21%)、软组织切除/重建(20%)和肢体挽救(13%)。相关肿瘤手术总数的变异性为 2.6,其中脊椎/骨盆(4.6)、儿科肿瘤病例(4.4)和并发症手术治疗(4.4)的变异性最大。研究期间的病例量变化趋势并不明显(P > 0.05)。对病例量百分位数进行分析后发现,至少有 30% 的肌肉骨骼肿瘤学研究员未达到儿科肿瘤病例的最低要求(n = 29 名研究员),10% 的研究员未达到相关肿瘤手术总数的最低要求(n = 10 名研究员):讨论:本研究的结果可帮助未来的肌肉骨骼肿瘤学研究员和教师确定在研究员培训期间增加病例接触和减少变异的潜在领域。需要进行更多调查,以确定循证病例最低要求,包括肌肉骨骼肿瘤学的手术学习曲线和其他基于能力的评估工具。
{"title":"Trends in Case Volume Reported by Musculoskeletal Oncology Fellows in Accreditation Council for Graduate Medical Education-Accredited Training Programs: 2017 to 2022.","authors":"Jason Silvestre, Zeke J Walton, Lee R Leddy","doi":"10.5435/JAAOS-D-24-00012","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00012","url":null,"abstract":"<p><strong>Introduction: </strong>Increasingly, national accrediting bodies and professional societies for musculoskeletal oncology recognize the need for more standardized training. This study elucidates recent trends in reported case volume during Accreditation Council for Graduate Medical Education (ACGME)-accredited musculoskeletal oncology fellowship training relative to case minimum requirements.</p><p><strong>Methods: </strong>We conducted a retrospective cross-sectional analysis of fellows at ACGME-accredited musculoskeletal oncology fellowships (2017 to 2022). Percentiles in reported case volumes were calculated across ACGME-defined case categories and temporal changes assessed by linear regression. Variability between the highest (90th percentile) and lowest (10th percentile) deciles was calculated as fold differences. Sensitivity analyses were conducted to estimate the number of fellows not meeting ACGME-defined case minimum requirements.</p><p><strong>Results: </strong>Case logs from 95 musculoskeletal oncology fellows were analyzed. From 2017 to 2022, total relevant oncology procedures increased from 191 ± 49 to 228 ± 73 (P = 0.066). Pediatric oncology accounted for a minority of cases (range, 6 to 8%). A mean of 222 total relevant oncology procedures were reported. Most were in management of metastatic disease (21%), soft-tissue resection/reconstruction (20%), and limb salvage (13%). Variability in total relevant oncology procedures was 2.6 and greatest in spine/pelvis (4.6), pediatric oncologic cases (4.4), and surgical management of complications (4.4). No clear trends were observed in case volume variability over the study period (P > 0.05). Analysis of case volume percentiles identified at least 30% of musculoskeletal oncology fellows not achieving minimum requirements for pediatric oncologic cases (n = 29 fellows) and 10% of fellows not achieving minimum requirements for total relevant oncology procedures (n = 10 fellows).</p><p><strong>Discussion: </strong>Results from this study may help future musculoskeletal oncology fellows and faculty identify potential areas to increase case exposure and reduce variability during fellowship training. More investigation is needed to determine evidence-based case minimum requirements including surgical learning curves and other competency-based assessment tools in musculoskeletal oncology.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142086416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Xylazine-Induced Soft-Tissue Necrosis: A Review of 20 Cases. 对赛拉嗪引起的软组织坏死的处理:20 例病例回顾
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-23 DOI: 10.5435/JAAOS-D-24-00125
Helene Retrouvey, Maximilian A Meyer, Kyros Ipaktchi, Andrew Maertens, Matthew Folchert, Alexander Lauder

Purpose: The illicit injection of xylazine has recently been designated as an emerging public health threat. The use of this drug is associated with devastating soft-tissue necrosis that may lead to limb amputation. This study aimed to (1) report cases of soft-tissue injury from xylazine and (2) describe a staging and management algorithm for wounds related to xylazine use.

Methods: A retrospective review was conducted to identify patients treated for xylazine-related soft-tissue necrosis at a trauma center. Clinical cases, treatment strategy, and available outcomes were presented. In addition, a comprehensive literature search was conducted using the keywords "xylazine" and "soft tissue."

Results: The management of seven patients with xylazine-related upper extremity soft-tissue necrosis was included, in addition to summarizing findings of five studies reporting on 13 additional cases. These cases were managed with local wound care (2 patients), soft-tissue reconstruction (4 patient), osseous reconstruction (1 patient), and limb amputation (10 patients).

Discussion: Acute treatment of xylazine-related soft-tissue necrosis is ideal to minimize morbidity and prevent limb loss. Management strategies of these wounds should be based on the depth of tissue involvement. Superficial ulceration involving the skin and subcutaneous tissue (Stage 1) should be managed with local wound care. Deeper ulceration involving tendons and/or muscle (Stage 2) requires surgical débridement and soft-tissue reconstruction. Deeper ulceration involving bone (Stage 3) requires osseous débridement and reconstruction. Finally, when all tissues in the extremity are involved (Stage 4), amputation is often necessary.

目的:非法注射异丙嗪最近被定为一种新出现的公共健康威胁。使用这种药物会造成破坏性软组织坏死,可能导致截肢。本研究旨在:(1) 报告因使用甲苯噻嗪而导致软组织损伤的病例;(2) 描述与使用甲苯噻嗪有关的伤口的分期和管理算法:方法:我们进行了一项回顾性研究,以确定在一家创伤中心接受过与甲苯噻嗪相关的软组织坏死治疗的患者。介绍了临床病例、治疗策略和现有结果。此外,还以 "甲苯噻嗪 "和 "软组织 "为关键词进行了全面的文献检索:除了总结五项研究对另外 13 例病例的报告结果外,还纳入了对七例与二甲苯嗪相关的上肢软组织坏死患者的治疗方法。这些病例的治疗方法包括局部伤口护理(2 例患者)、软组织重建(4 例患者)、骨重建(1 例患者)和截肢(10 例患者):讨论:木乃伊相关软组织坏死的急性治疗是降低发病率和防止肢体缺失的理想方法。这些伤口的处理策略应基于组织受累的深度。涉及皮肤和皮下组织的浅表溃疡(第 1 阶段)应通过局部伤口护理进行处理。涉及肌腱和/或肌肉的较深溃疡(第 2 阶段)需要进行手术清创和软组织重建。涉及骨骼的较深溃疡(第 3 阶段)需要进行骨清创和重建。最后,当肢体的所有组织都受累时(第 4 阶段),通常需要截肢。
{"title":"Management of Xylazine-Induced Soft-Tissue Necrosis: A Review of 20 Cases.","authors":"Helene Retrouvey, Maximilian A Meyer, Kyros Ipaktchi, Andrew Maertens, Matthew Folchert, Alexander Lauder","doi":"10.5435/JAAOS-D-24-00125","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00125","url":null,"abstract":"<p><strong>Purpose: </strong>The illicit injection of xylazine has recently been designated as an emerging public health threat. The use of this drug is associated with devastating soft-tissue necrosis that may lead to limb amputation. This study aimed to (1) report cases of soft-tissue injury from xylazine and (2) describe a staging and management algorithm for wounds related to xylazine use.</p><p><strong>Methods: </strong>A retrospective review was conducted to identify patients treated for xylazine-related soft-tissue necrosis at a trauma center. Clinical cases, treatment strategy, and available outcomes were presented. In addition, a comprehensive literature search was conducted using the keywords \"xylazine\" and \"soft tissue.\"</p><p><strong>Results: </strong>The management of seven patients with xylazine-related upper extremity soft-tissue necrosis was included, in addition to summarizing findings of five studies reporting on 13 additional cases. These cases were managed with local wound care (2 patients), soft-tissue reconstruction (4 patient), osseous reconstruction (1 patient), and limb amputation (10 patients).</p><p><strong>Discussion: </strong>Acute treatment of xylazine-related soft-tissue necrosis is ideal to minimize morbidity and prevent limb loss. Management strategies of these wounds should be based on the depth of tissue involvement. Superficial ulceration involving the skin and subcutaneous tissue (Stage 1) should be managed with local wound care. Deeper ulceration involving tendons and/or muscle (Stage 2) requires surgical débridement and soft-tissue reconstruction. Deeper ulceration involving bone (Stage 3) requires osseous débridement and reconstruction. Finally, when all tissues in the extremity are involved (Stage 4), amputation is often necessary.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142086413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex, Race, and Ethnicity of Faculty and Department Chairs in Orthopaedic Surgery and Comparable Fields: 2015 to 2022. 矫形外科和类似领域的教职员工和系主任的性别、种族和族裔:2015 年至 2022 年。
IF 2.6 2区 医学 Q1 ORTHOPEDICS Pub Date : 2024-08-23 DOI: 10.5435/JAAOS-D-24-00166
Jacob S Budin, Mia V Rumps, Mary K Mulcahey

Introduction: The field of orthopaedic surgery has disproportionately low numbers of women and underrepresented in medicine (URM) groups. Although the representation of women and URM in orthopaedics has increased over the past several years, the growth has not kept up with other surgical specialties.

Methods: This is a retrospective review of data presented by the Association of American Medical Colleges (AAMC) regarding US medical school faculty and department chair makeup in 2018 to 2022 and 2015 data from the AAMC Group on Women in Medicine and Sciences reports. Data regarding the sex and race/ethnicity of faculty and department chairs in orthopaedic surgery, a comparable surgical specialty (otolaryngology), surgery, and all medical fields were assessed. Otolaryngology was chosen as a comparable specialty because orthopaedic surgery and otolaryngology are the only two surgical specialties classified within the AAMC faculty report, separate from any medical counterpart.

Results: Among orthopaedic surgery, otolaryngology, surgery, and all clinical sciences, the representation of women and individuals from URM groups increased between 2015 and 2022. During this time, orthopaedic surgery had the lowest growth rate of the four groups in female faculty (+0.63%/year), URM faculty (+0.32%/year), and URM department chairs (+0.11%/year). However, orthopaedic surgery did have an increase in female department chairs (0.96%/year to 7% in 2022), similar to increases seen in surgery and all clinical sciences.

Discussion: The increase in representation in female and URM faculty and department chairs in orthopaedic surgery lags behind comparable fields and medicine as a whole. In addition, orthopaedic surgery had the lowest representation of female and URM faculty in 2015 and 2022. Improving the representation of female and URM orthopaedic faculty and department chairs is critical because this may encourage more diverse medical students to consider pursuing a career in the field.

简介:矫形外科领域的女性和在医学界代表性不足(URM)的群体人数少得不成比例。尽管在过去几年中,女性和URM在骨科领域的比例有所上升,但增长速度并没有跟上其他外科专科的步伐:这是对美国医学院协会(AAMC)提供的 2018 年至 2022 年美国医学院教师和系主任构成数据以及 2015 年美国医学院协会医学和科学界女性小组报告数据的回顾性审查。我们评估了骨科外科、类似外科专业(耳鼻喉科)、外科以及所有医学领域的教员和系主任的性别和种族/族裔数据。之所以选择耳鼻喉科作为可比专科,是因为矫形外科和耳鼻喉科是美国医学会教职员工报告中仅有的两个外科专科,与任何内科对应专科分开:结果:在骨科、耳鼻喉科、外科和所有临床科学专业中,2015 年至 2022 年间,女性和乌拉圭移民群体的人数有所增加。在此期间,骨科在女性教职员工(+0.63%/年)、URM 教职员工(+0.32%/年)和URM 系主任(+0.11%/年)方面的增长率在四个组别中最低。不过,矫形外科的女性系主任人数确实有所增加(每年增加 0.96%,到 2022 年达到 7%),与外科和所有临床科学的增幅相似:讨论:矫形外科中女性教职员工和少数民族教职员工以及系主任人数的增长落后于同类领域和整个医学界。此外,在 2015 年和 2022 年,矫形外科的女性和亚太裔教师比例最低。提高矫形外科女性和乌拉圭人教员及系主任的比例至关重要,因为这可以鼓励更多不同的医学生考虑从事该领域的工作。
{"title":"Sex, Race, and Ethnicity of Faculty and Department Chairs in Orthopaedic Surgery and Comparable Fields: 2015 to 2022.","authors":"Jacob S Budin, Mia V Rumps, Mary K Mulcahey","doi":"10.5435/JAAOS-D-24-00166","DOIUrl":"https://doi.org/10.5435/JAAOS-D-24-00166","url":null,"abstract":"<p><strong>Introduction: </strong>The field of orthopaedic surgery has disproportionately low numbers of women and underrepresented in medicine (URM) groups. Although the representation of women and URM in orthopaedics has increased over the past several years, the growth has not kept up with other surgical specialties.</p><p><strong>Methods: </strong>This is a retrospective review of data presented by the Association of American Medical Colleges (AAMC) regarding US medical school faculty and department chair makeup in 2018 to 2022 and 2015 data from the AAMC Group on Women in Medicine and Sciences reports. Data regarding the sex and race/ethnicity of faculty and department chairs in orthopaedic surgery, a comparable surgical specialty (otolaryngology), surgery, and all medical fields were assessed. Otolaryngology was chosen as a comparable specialty because orthopaedic surgery and otolaryngology are the only two surgical specialties classified within the AAMC faculty report, separate from any medical counterpart.</p><p><strong>Results: </strong>Among orthopaedic surgery, otolaryngology, surgery, and all clinical sciences, the representation of women and individuals from URM groups increased between 2015 and 2022. During this time, orthopaedic surgery had the lowest growth rate of the four groups in female faculty (+0.63%/year), URM faculty (+0.32%/year), and URM department chairs (+0.11%/year). However, orthopaedic surgery did have an increase in female department chairs (0.96%/year to 7% in 2022), similar to increases seen in surgery and all clinical sciences.</p><p><strong>Discussion: </strong>The increase in representation in female and URM faculty and department chairs in orthopaedic surgery lags behind comparable fields and medicine as a whole. In addition, orthopaedic surgery had the lowest representation of female and URM faculty in 2015 and 2022. Improving the representation of female and URM orthopaedic faculty and department chairs is critical because this may encourage more diverse medical students to consider pursuing a career in the field.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142086414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the American Academy of Orthopaedic Surgeons
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1